Understanding the Amyloid Hypothesis in Alzheimer's Disease

Giulia Paroni, Paola Bisceglia, Davide Seripa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The amyloid hypothesis (AH) is still the most accepted model to explain the pathogenesis of inherited Alzheimer's disease (IAD). However, despite the neuropathological overlapping with the non-inherited form (NIAD), AH waver in explaining NIAD. Thus, 30 years after its first statement several questions are still open, mainly regarding the role of amyloid plaques (AP) and apolipoprotein E (APOE). Accordingly, a pathogenetic model including the role of AP and APOE unifying IAD and NIAD pathogenesis is still missing. In the present understanding of the AH, we suggested that amyloid-β (Aβ) peptides production and AP formation is a physiological aging process resulting from a systemic age-related decrease in the efficiency of the proteins catabolism/clearance machinery. In this pathogenetic model Aβ peptides act as neurotoxic molecules, but only above a critical concentration [Aβ] c. A threshold mechanism triggers IAD/NIAD onset only when [Aβ]≥[Aβ] c. In this process, APOE modifies [Aβ] c threshold in an isoform-specific way. Consequently, all factors influencing Aβ anabolism, such as amyloid beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) gene mutations, and/or Aβ catabolism/clearance could contribute to exceed the threshold [Aβ] c, being characteristic of each individual. In this model, AP formation does not depend on [Aβ] c. The present interpretation of the AH, unifying the pathogenetic theories for IAD and NIAD, will explain why AP and APOE4 may be observed in healthy aging and why they are not the cause of AD. It is clear that further studies are needed to confirm our pathogenetic model. Nevertheless, our suggestion may be useful to better understand the pathogenesis of AD.

Original languageEnglish
Pages (from-to)493-510
Number of pages18
JournalJournal of Alzheimer's Disease
Volume68
Issue number2
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Amyloid Plaques
Amyloid
Alzheimer Disease
Apolipoproteins E
Presenilin-2
Physiological Phenomena
Presenilin-1
Peptides
Amyloid beta-Protein Precursor
Protein Isoforms
Mutation
Genes
Proteins

Keywords

  • Alpha-secretase
  • Alzheimer's disease
  • amyloid hypothesis
  • amyloid plaque
  • amyloid precursor protein
  • amyloid-alpha peptide
  • amyloid-beta peptide
  • apolipoprotein E
  • beta-secretase
  • inherited Alzheimer's disease
  • non-inherited Alzheimer's disease

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Understanding the Amyloid Hypothesis in Alzheimer's Disease. / Paroni, Giulia; Bisceglia, Paola; Seripa, Davide.

In: Journal of Alzheimer's Disease, Vol. 68, No. 2, 01.01.2019, p. 493-510.

Research output: Contribution to journalArticle

@article{c5d6ff834e6e45ebb06f88953fc6405b,
title = "Understanding the Amyloid Hypothesis in Alzheimer's Disease",
abstract = "The amyloid hypothesis (AH) is still the most accepted model to explain the pathogenesis of inherited Alzheimer's disease (IAD). However, despite the neuropathological overlapping with the non-inherited form (NIAD), AH waver in explaining NIAD. Thus, 30 years after its first statement several questions are still open, mainly regarding the role of amyloid plaques (AP) and apolipoprotein E (APOE). Accordingly, a pathogenetic model including the role of AP and APOE unifying IAD and NIAD pathogenesis is still missing. In the present understanding of the AH, we suggested that amyloid-β (Aβ) peptides production and AP formation is a physiological aging process resulting from a systemic age-related decrease in the efficiency of the proteins catabolism/clearance machinery. In this pathogenetic model Aβ peptides act as neurotoxic molecules, but only above a critical concentration [Aβ] c. A threshold mechanism triggers IAD/NIAD onset only when [Aβ]≥[Aβ] c. In this process, APOE modifies [Aβ] c threshold in an isoform-specific way. Consequently, all factors influencing Aβ anabolism, such as amyloid beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) gene mutations, and/or Aβ catabolism/clearance could contribute to exceed the threshold [Aβ] c, being characteristic of each individual. In this model, AP formation does not depend on [Aβ] c. The present interpretation of the AH, unifying the pathogenetic theories for IAD and NIAD, will explain why AP and APOE4 may be observed in healthy aging and why they are not the cause of AD. It is clear that further studies are needed to confirm our pathogenetic model. Nevertheless, our suggestion may be useful to better understand the pathogenesis of AD.",
keywords = "Alpha-secretase, Alzheimer's disease, amyloid hypothesis, amyloid plaque, amyloid precursor protein, amyloid-alpha peptide, amyloid-beta peptide, apolipoprotein E, beta-secretase, inherited Alzheimer's disease, non-inherited Alzheimer's disease",
author = "Giulia Paroni and Paola Bisceglia and Davide Seripa",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JAD-180802",
language = "English",
volume = "68",
pages = "493--510",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Understanding the Amyloid Hypothesis in Alzheimer's Disease

AU - Paroni, Giulia

AU - Bisceglia, Paola

AU - Seripa, Davide

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The amyloid hypothesis (AH) is still the most accepted model to explain the pathogenesis of inherited Alzheimer's disease (IAD). However, despite the neuropathological overlapping with the non-inherited form (NIAD), AH waver in explaining NIAD. Thus, 30 years after its first statement several questions are still open, mainly regarding the role of amyloid plaques (AP) and apolipoprotein E (APOE). Accordingly, a pathogenetic model including the role of AP and APOE unifying IAD and NIAD pathogenesis is still missing. In the present understanding of the AH, we suggested that amyloid-β (Aβ) peptides production and AP formation is a physiological aging process resulting from a systemic age-related decrease in the efficiency of the proteins catabolism/clearance machinery. In this pathogenetic model Aβ peptides act as neurotoxic molecules, but only above a critical concentration [Aβ] c. A threshold mechanism triggers IAD/NIAD onset only when [Aβ]≥[Aβ] c. In this process, APOE modifies [Aβ] c threshold in an isoform-specific way. Consequently, all factors influencing Aβ anabolism, such as amyloid beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) gene mutations, and/or Aβ catabolism/clearance could contribute to exceed the threshold [Aβ] c, being characteristic of each individual. In this model, AP formation does not depend on [Aβ] c. The present interpretation of the AH, unifying the pathogenetic theories for IAD and NIAD, will explain why AP and APOE4 may be observed in healthy aging and why they are not the cause of AD. It is clear that further studies are needed to confirm our pathogenetic model. Nevertheless, our suggestion may be useful to better understand the pathogenesis of AD.

AB - The amyloid hypothesis (AH) is still the most accepted model to explain the pathogenesis of inherited Alzheimer's disease (IAD). However, despite the neuropathological overlapping with the non-inherited form (NIAD), AH waver in explaining NIAD. Thus, 30 years after its first statement several questions are still open, mainly regarding the role of amyloid plaques (AP) and apolipoprotein E (APOE). Accordingly, a pathogenetic model including the role of AP and APOE unifying IAD and NIAD pathogenesis is still missing. In the present understanding of the AH, we suggested that amyloid-β (Aβ) peptides production and AP formation is a physiological aging process resulting from a systemic age-related decrease in the efficiency of the proteins catabolism/clearance machinery. In this pathogenetic model Aβ peptides act as neurotoxic molecules, but only above a critical concentration [Aβ] c. A threshold mechanism triggers IAD/NIAD onset only when [Aβ]≥[Aβ] c. In this process, APOE modifies [Aβ] c threshold in an isoform-specific way. Consequently, all factors influencing Aβ anabolism, such as amyloid beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) gene mutations, and/or Aβ catabolism/clearance could contribute to exceed the threshold [Aβ] c, being characteristic of each individual. In this model, AP formation does not depend on [Aβ] c. The present interpretation of the AH, unifying the pathogenetic theories for IAD and NIAD, will explain why AP and APOE4 may be observed in healthy aging and why they are not the cause of AD. It is clear that further studies are needed to confirm our pathogenetic model. Nevertheless, our suggestion may be useful to better understand the pathogenesis of AD.

KW - Alpha-secretase

KW - Alzheimer's disease

KW - amyloid hypothesis

KW - amyloid plaque

KW - amyloid precursor protein

KW - amyloid-alpha peptide

KW - amyloid-beta peptide

KW - apolipoprotein E

KW - beta-secretase

KW - inherited Alzheimer's disease

KW - non-inherited Alzheimer's disease

UR - http://www.scopus.com/inward/record.url?scp=85063789427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063789427&partnerID=8YFLogxK

U2 - 10.3233/JAD-180802

DO - 10.3233/JAD-180802

M3 - Article

C2 - 30883346

AN - SCOPUS:85063789427

VL - 68

SP - 493

EP - 510

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -